IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 195 filers reported holding IMMUNOGEN INC in Q4 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,544,001 | -8.2% | 1,294,518 | +9.1% | 0.05% | -7.0% |
| Q2 2023 | $22,382,047 | +98.9% | 1,186,118 | -59.5% | 0.06% | +96.6% |
| Q1 2023 | $11,253,573 | -30.8% | 2,930,618 | -10.6% | 0.03% | -35.6% |
| Q4 2022 | $16,264,425 | +13.0% | 3,279,118 | +8.9% | 0.04% | +7.1% |
| Q3 2022 | $14,399,000 | +13.2% | 3,012,418 | +6.6% | 0.04% | +16.7% |
| Q2 2022 | $12,721,000 | +8.6% | 2,826,818 | +14.8% | 0.04% | +16.1% |
| Q1 2022 | $11,719,000 | -26.9% | 2,461,918 | +14.0% | 0.03% | -22.5% |
| Q4 2021 | $16,030,000 | +31.6% | 2,160,318 | +0.6% | 0.04% | +25.0% |
| Q3 2021 | $12,178,000 | -37.9% | 2,147,722 | -27.8% | 0.03% | -38.5% |
| Q2 2021 | $19,601,000 | -17.9% | 2,974,318 | +0.9% | 0.05% | -21.2% |
| Q1 2021 | $23,878,000 | +40.3% | 2,947,918 | +11.8% | 0.07% | +46.7% |
| Q4 2020 | $17,015,000 | +137.6% | 2,637,918 | +32.6% | 0.04% | +125.0% |
| Q3 2020 | $7,160,000 | +41.0% | 1,988,818 | +80.2% | 0.02% | +33.3% |
| Q2 2020 | $5,077,000 | +48.3% | 1,103,618 | +9.9% | 0.02% | +15.4% |
| Q1 2020 | $3,424,000 | +2.8% | 1,004,018 | +53.9% | 0.01% | +62.5% |
| Q4 2019 | $3,330,000 | +165.1% | 652,318 | +25.7% | 0.01% | +166.7% |
| Q3 2019 | $1,256,000 | +18.2% | 518,818 | +5.9% | 0.00% | 0.0% |
| Q2 2019 | $1,063,000 | +1.5% | 489,718 | +26.8% | 0.00% | 0.0% |
| Q1 2019 | $1,047,000 | +5.7% | 386,218 | +87.0% | 0.00% | 0.0% |
| Q4 2018 | $991,000 | +12.4% | 206,518 | +121.7% | 0.00% | +50.0% |
| Q3 2018 | $882,000 | -71.5% | 93,134 | -70.7% | 0.00% | -75.0% |
| Q2 2018 | $3,091,000 | -57.1% | 317,634 | -53.6% | 0.01% | -60.0% |
| Q1 2018 | $7,200,000 | +89.2% | 684,452 | +15.3% | 0.02% | +100.0% |
| Q4 2017 | $3,805,000 | +5753.8% | 593,552 | +1751.8% | 0.01% | – |
| Q4 2016 | $65,000 | -38.1% | 32,052 | -17.9% | 0.00% | – |
| Q3 2016 | $105,000 | -77.7% | 39,052 | -74.5% | 0.00% | -100.0% |
| Q2 2016 | $471,000 | +163.1% | 153,018 | +721.9% | 0.00% | +100.0% |
| Q3 2015 | $179,000 | -20.8% | 18,618 | +18.5% | 0.00% | -50.0% |
| Q2 2015 | $226,000 | – | 15,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |